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Recent advances in endoscopic instrumentation and techni­
ques have led to a marked increase in the detection and endo­
scopic resection of early colorectal carcinomas.1 Although endo­
scopic complete resection of early colorectal cancer is currently 
accepted as curative therapy due to the relatively low risk of 
lymph node metastasis,2,3 about 10% of patients with submu­
cosal invasive colorectal carcinoma (SICC) have synchronous 
metastases to regional lymph nodes.2,4 It is therefore necessary 
to stratify patients with SICC into low­risk and high­risk groups 
to determine the risks of lymph node metastasis5 and to elect 
proper additional management. The pathological features asso­
ciated with lymph node metastasis in patients with SICC in­
clude poor differentiation, deep invasion into the submucosal 
layer, and lymphatic channel invasion.3,6,7 More recently, tumor 
budding has been shown to reflect the biologic aggressiveness 
of colorectal cancers. Herein, we describe two patients with small 
SICC and tumor budding, resulting in adverse outcomes within 
5 years, despite favorable tumor histology and complete resec­
tion.
CASE REPORTS
Case 1 was a 68­year­old female patient who was admitted 
for further treatment of an incidentally detected rectal polyp. 
Colonoscopic examination (Fig. 1A) showed a 2 cm­sized semi­
pedunculated polyp, 7 cm from the anal verge. A biopsy showed 
an adenocarcinoma with a background of tubulovillous adeno­
ma. Since preoperative computed tomography (CT) showed no 
evidence of lymph node or distant metastasis, she underwent 
transanal endoscopic microsurgery with full thickness of exci­
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sion in August 2003. Histologic examination revealed a 3.5 mm­
sized, well differentiated adenocarcinoma invading the submu­
cosa at a depth of 1.2 mm from the muscularis mucosa (sm1; 
thickness of submucosal layer 4 mm) (Fig. 1B). Since no lymph 
nodes were included within the perirectal fat, the pathologic 
stage was pT1NX. The nearest safety margin to carcinoma was 
1.3 cm (deep margin). There was no definitive evidence of lym­
phatic invasion at first pathologic diagnosis, and she therefore 
received no additional therapy. In April 2008, an abdominal 
CT performed during routine follow­up revealed a 2 cm­sized 
nodular lesion in her perirectal fat (Fig. 2A). Anterior resection 
was performed, and histologic examination showed that this 
tumor, which involved the perirectal adipose tissue with no me­
tastasis out of 15 regional lymph nodes (rpT0N1c), was com­
patible with a recurrence of the previous rectal cancer (Fig. 2B). 
Case 2 was a 53­year­old male patient with tenesmus that 
had undergone a colonoscopy, which revealed a 1 cm­sized flat­
elevated lesion with central depression in the sigmoid colon, 25 
cm from the anal verge (Fig. 3A). He underwent anterior resec­
tion in March 2004, and histologic examination showed that 
the tumor was a 5 mm­sized, moderately differentiated adeno­
carcinoma invading the submucosa (sm3) (Fig. 3B). The depth 
of submucosal invasion was 2.5 mm and the safety margin was 
at least 3 cm. No metastases were detected out of six pericolic 
lymph nodes, and the patient did not receive any adjuvant treat­
ment. In February 2008, the patient developed widespread re­
currence of the cancer (Fig. 4A) and underwent a low anterior 
resection with paraaortic lymph node dissection and segmental 
A B
Fig. 1. Endoscopic and histologic findings of primary tumor in case 1. (A) Colonoscopic examination shows subpedunculated mass in the 
rectum with an ill-defined boundary. (B) Pathologic examination reveals a rectal cancer infiltrating the submucosa, with an adenoma compo-
nent at the periphery.
A B
Fig. 2. Radiologic and histologic findings of recurrent tumor in case 1. (A) A newly appeared soft tissue mass (arrow) in the perirectal tissue is 
detected upon computed tomographic imaging. (B) A perirectal mass shows an adenocarcinoma with intraluminal necrosis.
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resection of the small intestine. Pathologic examination revealed 
a recurrent adenocarcinoma extended to the periureteral soft 
tissue and multiple metastases to the small intestine, regional 
and para­aortic lymph nodes (rpT4N2bM1b) (Fig. 4B).
Retrospective pathologic review of the two primary carcino­
mas showed tumor buddings, defined as multiple foci of a sin­
gle cancer cell and/or a micro­nest composed of several tumor 
cells, at the invasive front of both primary tumors (Fig. 5). A 
magnification of ×400 showed more than 10 foci in both pri­
mary tumors. In addition, small endolymphatic tumor emboli 
were detected only after deeper cutting of the paraffin blocks in 
both cases. These minute lymphatic invasion were not observed 
on the orginial hematoxylin and eosin slides. In both patients, 
the presence of tumor budding and lymphatic invasion was con­
firmed by immunohistochemical assays for cytokeratin and D2­
40, respectively (Fig. 6). Immunohistochemical staining was 
performed using a mouse monoclonal antibody for cytokeratin 
(1 :500, Dako, Glostrup, Denmark) and D2­40 (1 :200, Dako).
DISCUSSION
Complete endoscopic resection of intramucosal carcinomas in 
the colorectum is regarded as curative, as there is no risk of lym­
ph node metastasis.2,8 In contrast, lymph node metastasis is 
present in 6­12% of patients with SICC. Positive lymph node 
status has been reported to be the only significant independent 
predictor of 5­year cancer specific survival and 5­year disease­
free survival in patients with pT1 and pT2 colorectal cancers.9 
A B
Fig. 3. Endoscopic and histologic findings of primary tumor in case 2. (A) Colonoscopic examination shows an elevated tumor with central 
depression in the sigmoid colon. (B) Pathologic examination reveals a colon cancer invading the submucosa.
A B
Fig. 4. Radiologic and histologic findings of recurrent tumor in case 2. (A) Multiple metastatic lesions (arrows) in the para-aortic lymph node 
and mesentery are identified on computed tomographic imaging. (B) Adenocarcinoma involves the small intestinal mucosa, with similar his-
tological findings to the original tumor (Fig. 2B). 
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Fig. 5. Tumor buds at the invasive front of primary tumors (arrows). 
(A, B) In case 1, subtle budding cells (A) around the tumor margins 
are highlighted by immunohistochemistry using antibody to cyto-
keratin (B). (C) In case 2, frequent tumor budding is observed in a 
high power field.
A
B
C
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B
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Fig. 6. Lymphatic invasion in the primary tumors. (A, B) In case 1, 
several atypical cells are observed in the lymphatic channel (A) and 
proven to be carcinoma cells positive for cytokeratin (B). (C) In case 
2, endolymphatic tumor emboli at the tumor border are confirmed 
by antibody to D2-40.
The standard of care for node­positive colorectal cancer patients 
is adjuvant chemotherapy based on 5­flourouracil regimens.10 
Therefore, it is critical to evaluate the likelihood of lymph node 
metastasis in SICC. Poorly differentiated histology, presence of 
deep submucosal invasion, and lymphatic invasion are predic­
tors of lymph node metastasis in patients with T1 colorectal 
cancer.3,6,7 Most T1 lesions without adverse pathologic features 
can be locally excised because the risks of local recurrence and 
lymph node metastasis are very low. However, a T1 lesion with 
unfavorable histologic features has a high risk of local recurrence 
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and lymph node metastasis, whether metachronous or synchro­
nous, indicating the need for additional treatment,2 since the 
prognosis is worse for patients who undergo additional surgery 
after local recurrence or lymph node metastasis.
Tumor budding, or the presence of isolated single tumor cells 
or small cell clusters (up to 4 cells) scattered in the stroma at 
the invasive tumor margins, has been considered a malignant 
characteristic of colorectal carcinomas.11,12 Tumor budding is 
observed in many colorectal carcinomas and has been reported 
to be a useful predictor of patient outcome13,14 and lymph node 
metastasis6,7,12,13,15 in T1 colorectal cancer. Rectal cancer patients 
having a tumor budding intensity of >10 foci within a micro­
scopic field of ×250 had lower 5­year survival rates than pa­
tients with tumor budding intensity of <10. Moreover, high­
grade “tumor budding activity,” defined as 10 or more foci in a 
microscopic field of ×200, has been closely associated with lym­
phatic involvement and lymph node metastasis in SICC.16 Im­
munophenotypically, loss of E­cadherin in budding cells of col­
orectal cancers has been reported, with loss of E­cadherin within 
the main tumor body being significantly associated with tumor 
budding.17
Both patients described here had tumors with moderate to 
well differentiated histology and safety margins were sufficient 
for complete resection. However, recurrent disease developed 
within relatively short intervals. In the first patient, tumor re­
currence without lymph node metastasis was observed 4.7 years 
after local tumor excision. In the second patient, both locore­
gional and systemic recurrences were observed 3.9 years after 
surgical resection, although lymph node metastasis was not 
identified in the primary tumor. Since a study of endoscopical­
ly­resected SICC demonstrated that recurrent primary cancers 
were significantly associated with poorly differentiated histolo­
gy,18 we believed that other factors may have contributed to 
disease recurrence in these 2 patients. A thorough retrospective 
histologic review revealed frequent tumor budding from both 
tumors. Lymphatic channel permeation was not initially appar­
ent on hematoxylin and eosin staining alone but was detected 
only after deeper cutting of the paraffin blocks and additional 
immunohistochemical assays. Similar to our patients was a pa­
tient with a submucosal invasive colon cancer of the peduncu­
lated type, who developed lung metastasis 6 years after curative 
endoscopic polypectomy.19 The lesion was a 1 cm­sized, well 
differentiated adenocarcinoma showing tumor budding in the 
invasive front without lymphatic invasion, suggesting that tu­
mor budding may be a significant prognostic factor for cancer 
recurrence and distant metastasis. Moreover, tumor budding 
may be closely associated with lymphatic channel involvement 
and lymph node metastasis. Although lymphatic invasion is re­
garded as an important prognostic factor for patients with SICC, 
lymphatic invasion may be subjective and be overestimated or 
underestimated due to retraction artifacts related to tissue pro­
cessing for paraffin blocks.20 In contrast to angiolymphatic in­
vasion, detection of tumor budding is more objective. More­
over, tumor budding may reflect early lymphatic invasion, even 
in the absence of definite lymphatic invasion. Consequently, 
meticulous pathologic examination is needed to detect tumor 
budding and angiolymphatic invasion in patients with SICC. 
Furthermore, immunohistochemical staining for D2­40 and 
cytokeratin may be helpful in detecting tumor budding and 
lymphatic channel permeation.
To our knowledge, this is the first report of cases in Korea of 
SICC showing tumor budding with advanced recurrences. Mul­
tiple tumor budding at the invasive front may predict tumor 
aggressiveness in SICC. Further pathologic examination for lym­
phatic invasion such as deeper section or immunohistochemisty 
is needed in cases with SICC that have frequent tumor budding 
in which lymphatic invasion is not seen in the original hema­
toxylin and eosin slides. Besides, more aggressive follow­up is 
necessary for SICC patients showing tumor budding, even in 
the absence of unfavorable histologic findings. Other supple­
mentary treatment measures, such as adjuvant chemotherapy, 
may be required to prevent recurrence and metastasis in these 
patients.
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